Who is sponsoring NCT03494803?

NCT03494803 is sponsored by HKGepitherapeutics.

What condition does NCT03494803 study?

NCT03494803 studies Prostate Cancer, Prostate Adenocarcinoma, Prostate Cancer Metastatic.

What is the status of NCT03494803?

NCT03494803 is currently WITHDRAWN.

Last reviewed 2023-12-22 · How we verify

Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC

NCT03494803 WITHDRAWN

Prostate cancer is a leading cause of mortality and morbidity. The purpose of this study is to develop and test non-invasive biomarkers based on methylation changes in PBMC, T-cells and circulated tumor DNA in prostate cancer patients.

Details

Lead sponsor	HKGepitherapeutics
Status	WITHDRAWN
Start date	Fri Jun 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Dec 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Prostate Cancer
Prostate Adenocarcinoma
Prostate Cancer Metastatic

Countries

Kazakhstan